-
Sort By
-
Newest
-
Newest
-
Oldest
BARD1 Life Sciences (ASX: BD1) – Earlier in the week, the Inside Investor team published an article on BARD1 Life Sciences (click here) and its meteoric rise following a positive announcement on ovarian cancer detection. Shares have risen from 74.5c on the day of the announcement to $3.20 at the time of writing. That’s a…